City of Hope Medical Center clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 674 studies whose lead sponsor is City of Hope Medical Center. 178 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 23, 2026.
Keep track of what changes. Save the City of Hope Medical Center studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesFocus areas
Conditions City of Hope Medical Center leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Breast Neoplasms86Leukemia, Myeloid, Acute51Myelodysplastic Syndromes46Lymphoma43Precursor Cell Lymphoblastic Leukemia-Lymphoma42Neoplasms41Colorectal Neoplasms40Lung Neoplasms39Multiple Myeloma35Prostatic Neoplasms35Leukemia34Leukemia, Lymphocytic, Chronic, B-Cell28Lymphoma, Mantle-Cell26Lymphoma, Non-Hodgkin25Hodgkin Disease24Carcinoma, Non-Small-Cell Lung23Lymphoma, Large B-Cell, Diffuse23Carcinoma, Renal Cell22Colonic Neoplasms22Pancreatic Neoplasms22Lymphoma, Follicular21Myeloproliferative Disorders21Rectal Neoplasms21Hematologic Neoplasms20
Show all 47 areas
Glioblastoma19Neoplasm Metastasis18Stomach Neoplasms17Burkitt Lymphoma15Carcinoma15Ovarian Neoplasms15Primary Myelofibrosis14Brain Neoplasms13Lymphoma, B-Cell, Marginal Zone13Carcinoma, Hepatocellular12Graft vs Host Disease12Lymphoma, T-Cell12Sarcoma12Carcinoma, Ovarian Epithelial11Leukemia, Myeloid, Accelerated Phase11Leukemia, Myeloid, Chronic-Phase11Lymphoma, B-Cell11Lymphoma, T-Cell, Cutaneous11Myelodysplastic-Myeloproliferative Diseases11Plasmacytoma11Leukemia, Myelogenous, Chronic, BCR-ABL Positive10Liver Neoplasms10Mycosis Fungoides10
Studies
Recruiting first, then most recently updated. Showing 50 of 674. Browse all 674 →
- CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell TransplantRecruitingNCT06059391Phase 2
- A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell TransplantRecruitingNCT07020533Phase 1
- Ivonescimab Prior to Surgery for the Treatment of High-Risk Localized Clear Cell Renal Cell CancerRecruitingNCT07226544Phase 2
- Locoregional Administration of Genetically Engineered Cells (EGFR/IL13Rα2 Pool-CAR T Cells) for the Treatment of Recurrent or Progressive High-Grade GliomasRecruitingNCT07544992Phase 1
- Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant AstrocytomaRecruitingNCT06815029Phase 1
- Biospecimen Analysis in Detecting Chemical Concentrations in Patients With Chronic or Infectious Diseases Receiving MeditationsRecruitingNCT04160429
- Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART StudyRecruitingNCT06052826Phase 2
- Golcadomide in Combination With Rituximab for the Treatment of Patients With Relapsed or Refractory Mantle Cell LymphomaRecruitingNCT07578077Phase 1/2
- A Wearable Biosensor Patch for Non-Invasive Monitoring for Patients Undergoing Abdominal or Chest SurgeryNot yet recruitingNCT07612085Not applicable
- Denosumab for Type 1 DiabetesRecruitingNCT06524960Phase 1/2
- AOH1996 for the Treatment of Refractory Solid TumorsRecruitingNCT05227326Phase 1
- Olutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell TransplantRecruitingNCT06543381Phase 1
- Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Treating Pediatric Patients With Positive Cytomegalovirus Undergoing Donor Stem Cell TransplantRecruitingNCT03354728Phase 1/2
- Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic CancerRecruitingNCT06454383Phase 1
- Geriatric Assessment and Management for Older Adults Undergoing Chemotherapy and Radiation Therapy for Head and Neck Cancer and Their Family CaregiversRecruitingNCT07225855Not applicable
- Environmental Exposure Assessment in High-Risk and Early-Onset Breast Cancer CareRecruitingNCT07690852
- Telemedicine for Improvement of Care for Older Adults With Cancer in the Underserved Community, The GAIN-S TrialRecruitingNCT06022965Not applicable
- Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell TransplantRecruitingNCT06575296Phase 1
- Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary CancersRecruitingNCT05519878Not applicable
- Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing ChemotherapyRecruitingNCT06763328Phase 3
- Asciminib as Maintenance Treatment After Cellular Therapies for Adults With Philadelphia Chromosome Positive Acute Lymphoblastic LeukemiaRecruitingNCT07040982Phase 1
- A PET Imaging Agent (64Cu-DOTA-Pembrolizumab) for Determining Treatment Response Among Patients With Stage IV Non-small Cell Lung Cancer Receiving PembrolizumabRecruitingNCT07619599Phase 1
- Duvelisib Maintenance for the Treatment of Peripheral T-Cell LymphomasRecruitingNCT07293403Phase 2
- Adding a Live Biotherapeutic Product (CBM588) to Pembrolizumab for the Treatment of Renal Cell Cancer After SurgeryRecruitingNCT07037004Phase 2
- Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3RecruitingNCT07595874Phase 2
- Provider-Mediated Communication of Genetic Testing Results to At-Risk Relatives of Cancer Patients to Improve Genetic Counseling and Testing Rates, Family HOPE StudyRecruitingNCT05772130Not applicable
- Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.RecruitingNCT04305834Phase 2
- Study to Detect Changes in Urinary and Gut Microbiome During Androgen Deprivation Therapy and Radiation Therapy in Patients With Prostate CancerRecruitingNCT04775355
- Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid NodulesRecruitingNCT05229341Not applicable
- Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP TrialRecruitingNCT07288034Phase 2
- A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 DiabetesRecruitingNCT07061574Phase 1/2
- Fluorescence-Guided Surgical Resection for Reducing Unexpected Positive Margins in Patients With Sarcoma, SarcoSIGHT TrialRecruitingNCT07650656Phase 2
- Recombinant Erwinia Asparaginase and Venetoclax in Combination With Blinatumomab for the Treatment of Relapsed or Refractory CD19 Positive B-cell Acute Lymphoblastic LeukemiaRecruitingNCT07133997Phase 1
- Mindfulness Intervention to Reduce Patient Reported Symptoms in Patients With Chronic Graft-Versus-Host DiseaseRecruitingNCT07733141Not applicable
- A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast CancerRecruitingNCT07741968Not applicable
- Improving Islet Transplantation Outcomes With Gastrin for Type I DiabetesRecruitingNCT03746769Phase 1/2
- CAR T Cells After Lymphodepletion for the Treatment of IL13Rα2 Positive Recurrent or Refractory Brain Tumors in ChildrenRecruitingNCT04510051Phase 1
- Pacritinib in Combination With a BTK Inhibitor for the Treatment of Patients With Relapsed or Refractory Mantle Cell LymphomaRecruitingNCT06675123Phase 1
- Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell LymphomaRecruitingNCT03523975Phase 1/2
- Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic SyndromeRecruitingNCT06128070Phase 2
- Aromatherapy Essential Oils to Manage Anxiety and Nausea in Cancer Patients Receiving Infusion in the Ambulatory SettingRecruitingNCT07126301Not applicable
- Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaRecruitingNCT06918431Phase 2
- The da Vinci Single Port Robotic System for Use in Abdominal and Pelvic Surgical ProceduresRecruitingNCT05672368Phase 2
- Loncastuximab Tesirine and Mosunetuzumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell LymphomaRecruitingNCT05672251Phase 2
- Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic SyndromeRecruitingNCT07582172Phase 2
- Tear Fluid for the Detection of Tumor-associated Extracellular Vesicles in Glioblastoma PatientsRecruitingNCT07775534Not applicable
- Bright White Light Therapy in Reducing Cancer-Related Fatigue and Depression in Advanced Prostate Cancer Patients Undergoing Treatment With ADT Combination TherapyRecruitingNCT05869682Phase 2
- Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast CancerRecruitingNCT06260033Phase 2
- Individualized AML TreatmentRecruitingNCT07613385
- Kinetic Analysis of Immune Cells in Blood and Chronic Graft-Versus-Host Disease-Affected Tissues After Allogeneic Hematopoietic Cell TransplantationRecruitingNCT07235501